Also, hepatic APPs exert liver protection by countering TNF-dependent toxicity in the liver and attenuate systemic inflammation and mortality in sepsis and pneumonia-induced ARDS (Fig. 1) [79, 86, 88–90]. This evidence concerns the gene TNF and acute respiratory distress syndrome.